Pritchard P H
Department of Pathology, University of British Columbia, Vancouver, Canada.
Biochem J. 1987 Sep 15;246(3):791-4. doi: 10.1042/bj2460791.
The degradation of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human plasma is brought about by a specific acetylhydrolase that is associated with low-density lipoprotein. In this study, the presence of a similar activity on high-density lipoprotein (HDL) of rat plasma has been demonstrated which is independent of lecithin-cholesterol acyltransferase (LCAT) activity. Furthermore, PAF acetylhydrolase activity may be decreased by 66% by treatment of rats with 17 alpha-ethynyloestradiol (1 mg/kg body wt.; 5 days). This treatment also decreased HDL cholesterol concentrations by 90%, but did not affect LCAT activity. Thus rat LCAT and PAF acetylhydrolase are associated with different subspecies of HDL.
人血浆中血小板活化因子(PAF;1-O-烷基-2-乙酰基-sn-甘油-3-磷酸胆碱)的降解是由一种与低密度脂蛋白相关的特异性乙酰水解酶引起的。在本研究中,已证实在大鼠血浆的高密度脂蛋白(HDL)上存在类似活性,且该活性独立于卵磷脂胆固醇酰基转移酶(LCAT)活性。此外,用17α-乙炔雌二醇(1mg/kg体重;5天)处理大鼠可使PAF乙酰水解酶活性降低66%。该处理还使HDL胆固醇浓度降低了90%,但不影响LCAT活性。因此,大鼠LCAT和PAF乙酰水解酶与HDL的不同亚类相关。